Interim Financial Statements for the quarter ended 31st December 2024

Three

Three months

Variance

Nine months

Nine months to

Variance

months to

to

%

to

%

31 December

2024

2023

2024

2023

(In Rs.Mns)

Revenue

25,831.46

25,368.45

1.83

64,662.91

60,156.99

7.49

Cost of sales

(19,136.82)

(18,822.77)

1.67

(47,935.24)

(44,347.30)

8.09

Gross profit

6,694.64

6,545.68

2.28

16,727.67

15,809.69

5.81

Other income

105.01

54.25

93.57

219.40

229.54

(4.42)

Distribution expenses

(2,101.07)

(1,725.13)

21.79

(5,747.32)

(4,494.23)

27.88

Administrative expenses

(938.00)

(857.94)

9.33

(2,747.56)

(2,468.86)

11.29

Impairment loss on trade receivables

(26.75)

(64.73)

(58.67)

(63.02)

(246.51)

(74.44)

Other expenses

(0.10)

-

(100.00)

(0.16)

(106.13)

(99.85)

Results from operating activities

3,733.73

3,952.13

(5.53)

8,389.01

8,723.50

(3.83)

Finance income

158.18

214.09

(26.12)

557.59

640.06

(12.88)

Finance cost

(682.42)

(888.28)

(23.18)

(1,836.51)

(2,707.09)

(32.16)

Finance cost (net)

(524.24)

(674.19)

(22.24)

(1,278.92)

(2,067.03)

(38.13)

Gain on bargain purchase

443.16

5,121.70

(91.35)

473.45

5,121.70

(90.76)

Loss on dilution of investment in associate

-

-

-

(19.61)

-

(100.00)

Share of profit of equity accounted investees

299.26

289.55

3.35

539.72

452.43

19.29

Profit before tax

3,951.92

8,689.19

(54.52)

8,103.66

12,230.60

(33.74)

Tax expense

(1,090.40)

(1,006.35)

8.35

(2,420.02)

(2,580.64)

(6.22)

Profit from continuing operations

2,861.52

7,682.84

(62.75)

5,683.64

9,649.96

(41.10)

Discontinued operations

Gain from discontinued operations (net of tax)

4.28

2.71

57.93

14.09

17.49

(19.44)

Profit for the period

2,865.80

7,685.55

(62.71)

5,697.73

9,667.45

(41.06)

Other comprehensive income

Net gain/(loss) on fair value change in financial assets

183.66

(209.01)

(187.87)

224.97

3,772.42

(94.04)

Equity-accounted investees- share of OCI

170.16

(82.11)

(307.23)

18.34

(82.11)

(122.34)

Other comprehensive income for the period (net of tax)

353.82

(291.12)

(221.54)

243.31

3,690.31

(93.41)

Total comprehensive income for the period (net of tax)

3,219.62

7,394.43

(56.46)

5,941.04

13,357.76

(55.52)

Profit Attributable to :

Equity holders of the Company

2,534.99

7,237.28

(64.97)

4,853.62

8,647.38

(43.87)

Non-controlling interest

330.81

448.27

(26.20)

844.11

1,020.07

(17.25)

Profit for the period

2,865.80

7,685.55

(62.71)

5,697.73

9,667.45

(41.06)

Equity holders of the Company

264.24

(273.32)

(196.68)

147.41

3,325.88

(95.57)

Non-controlling interest

89.58

(17.80)

(603.26)

95.90

364.43

(73.68)

Other comprehensive income for the period

353.82

(291.12)

(221.54)

243.31

3,690.31

(93.41)

Earnings per share

Basic/diluted earnings per share (Rs.)

6.69

19.09

(64.97)

12.80

22.81

(43.87)

Earnings per share-continuing operation

Basic/diluted earnings per share (Rs.)

6.68

19.09

(64.99)

12.78

22.79

(43.90)

Company

Group

31st

31st

31st

31st

December

December

31st March

December

December

31st March

As at

2024

2023

2024

2024

2023

2024

(In Rs.Mn)

ASSETS

Non- current assets

Property, plant & equipment

2,311.91

2,358.49

2,337.74

12,621.20

12,484.69

12,608.28

Investment property

-

-

-

2.40

2.40

2.40

Capital work-in-progress

27.71

-

-

171.57

97.41

94.56

Biological assets

-

-

-

411.96

494.55

504.36

Intangible assets

25.75

33.65

31.68

604.79

630.94

625.21

Deferred tax assets

-

-

-

8.56

7.96

251.31

Investment in subsidiaries

3,734.96

3,593.21

3,734.96

-

-

-

Investment in equity accounted investees

17,123.20

15,645.06

16,312.02

29,277.67

24,880.65

25,206.12

Equity investment at fair value through OCI

-

-

-

0.15

0.18

0.15

Deposits with bank

-

-

-

0.29

0.29

0.29

23,223.53

21,630.41

22,416.39

43,098.59

38,599.07

39,292.68

Current assets

Inventories

4,850.91

4,167.85

5,184.72

16,456.62

17,084.58

18,449.04

Biological assets

-

-

-

347.27

396.45

299.77

Income tax receivables

-

-

-

0.21

0.23

0.71

Trade receivables

5,293.97

3,551.21

3,422.28

13,254.02

10,789.71

9,237.53

Contract assets

104.48

89.24

104.48

159.57

131.66

156.93

Other receivables

809.42

1,024.56

1,010.59

3,992.97

3,337.98

3,318.30

Equity investment at fair value through OCI

65.99

36.23

40.06

529.31

259.20

287.27

Deposits with bank

1,617.14

1,713.47

1,611.24

1,934.61

2,352.67

1,618.71

Cash in hand and at bank

920.69

648.65

590.36

6,206.24

6,277.86

5,416.04

13,662.60

11,231.21

11,963.73

42,880.82

40,630.34

38,784.30

Assets classified as held for sale

146.27

146.27

146.27

354.01

349.34

350.96

Assets classified as held for distribution

0.20

0.20

0.20

63.51

61.84

59.32

13,809.07

11,377.68

12,110.20

43,298.34

41,041.52

39,194.57

Total assets

37,032.60

33,008.09

34,526.59

86,396.93

79,640.59

78,487.26

EQUITY AND LIABILITIES

Equity attributable to equity holders of the company

Stated capital

1,008.45

1,008.45

1,008.45

1,008.45

1,008.45

1,008.45

Capital reserves

950.24

950.24

950.24

2,412.46

2,410.22

2,412.47

Revenue reserves

9,993.31

9,277.28

9,930.44

35,512.64

30,541.76

31,472.23

11,952.00

11,235.97

11,889.13

38,933.55

33,960.43

34,893.14

Non-controlling interests

-

-

-

5,958.06

5,042.25

5,101.74

Total equity

11,952.00

11,235.97

11,889.13

44,891.61

39,002.67

39,994.88

Non-current liabilities

Loans and borrowings

1,996.26

73.99

70.13

2,370.12

333.51

399.98

Retirement benefit obligations

408.71

257.71

339.73

1,473.55

1,004.06

1,300.69

Grants

-

-

-

1.24

1.42

1.37

Deferred tax liabilities

128.16

268.61

91.44

1,550.27

1,893.96

1,850.25

2,533.13

600.31

501.30

5,395.18

3,232.95

3,552.30

Current liabilities

Trade payables

2,175.23

1,460.55

2,318.96

4,596.36

4,407.53

4,763.85

Contract liabilities

148.41

130.99

148.41

249.98

221.00

246.53

Income tax payable

318.98

331.26

82.17

1,321.15

1,383.38

1,020.46

Accruals and other payables

1,355.76

1,502.83

1,241.32

4,297.61

3,948.10

3,332.73

Contigent consideration payable

108.05

55.65

138.05

108.05

55.65

138.05

Loans and borrowings

18,441.04

17,690.53

18,207.25

25,135.57

26,945.00

25,025.62

22,547.47

21,171.81

22,136.16

35,708.72

36,960.66

34,527.24

Liabilities classified as held for sale

-

-

-

399.86

442.45

411.01

Liabilities classified as held for distribution

-

-

-

1.56

1.86

1.83

22,547.47

21,171.81

22,136.16

36,110.14

37,404.97

34,940.09

Total liabilities

25,080.60

21,772.12

22,637.46

41,505.32

40,637.92

38,492.38

Total equity and liabilities

37,032.60

33,008.09

34,526.59

86,396.93

79,640.59

78,487.26

Net assets per share (Rs.)

31.53

29.64

31.36

102.71

89.59

92.05

(Sgd.) S H Amarasekera

(Sgd.) P R Saldin

Chairman

Director

For the period ended 31 December

Company

Stated

Revaluation

General

Fair Value

Retained

Total

Capital

Reserve

Reserves

Reserve

Earnings

(In Rs. Mns)

As at 01 April 2024

1,008.45

950.24

782.60

(3.14)

9,150.97

11,889.12

Profit for the period

-

-

-

-

984.65

984.65

Dividend

-

-

-

-

(947.70)

(947.70)

Other comprehensive income

-

-

-

25.93

-

25.93

As at 31 December 2024

1,008.45

950.24

782.60

22.79

9,187.92

11,952.00

As at 01 April 2023

1,008.45

1,716.06

782.60

(103.70)

3,992.67

7,396.08

Profit for the period

-

-

-

-

1,785.66

1,785.66

Derecognition of fair value reserve due to change in ownership of investments

-

-

-

(2,904.31)

2,904.31

-

Dividend

-

-

-

-

(947.70)

(947.70)

Other comprehensive income

-

-

-

3,001.93

-

3,001.93

Realisation of capital reserve

-

(765.82)

-

-

765.82

-

As at 31 December 2023

1,008.45

950.24

782.60

(6.08)

8,500.76

11,235.97

Group

Attributable to the equity holders of the company

Non-

Stated

Capital Reserve

General Reserve

Fair Value

Retained

Total

controlling

Total Equity

Capital

Reserve

Earnings

interest

(In Rs. Mn's)

As at 01 April 2024

1,008.45

2,412.46

720.31

(33.74)

30,785.66

34,893.14

5,101.73

39,994.87

Profit for the period

-

-

-

-

4,853.62

4,853.62

844.11

5,697.73

Other comprehensive income

-

-

-

130.37

17.04

147.41

95.90

243.31

Adjustment due to change in equity accounted investee

-

-

-

-

20.52

20.52

1.54

22.06

Dividend

-

-

-

-

(947.70)

(947.70)

-

(947.70)

Adjustment on non-controlling interest

-

-

-

-

(33.44)

(33.44)

33.44

-

Subsidiary dividend paid to non-controlling interest

-

-

-

-

-

-

(118.66)

(118.66)

As at 31 December 2024

1,008.45

2,412.46

720.31

96.63

34,695.70

38,933.55

5,958.06

44,891.61

As at 01 April 2023

1,008.45

3,165.11

720.31

(225.58)

18,327.73

22,996.02

4,832.99

27,829.01

Derecognition of fair value reserve due to change in ownership of investments

-

-

-

(3,228.75)

3,228.75

-

-

-

Profit for the period

-

-

-

-

8,647.38

8,647.38

1,020.07

9,667.45

Other comprehensive income

-

-

-

3,407.58

(81.70)

3,325.88

364.43

3,690.31

Adjustment due to change in holding

-

10.93

-

-

(72.08)

(61.15)

(138.84)

(200.00)

Dividend

-

-

-

-

(947.70)

(947.70)

-

(947.70)

Transfer due to disposal of assets

-

(765.82)

-

-

765.82

-

-

-

Subsidiary dividend paid to non-controlling interest

-

-

-

-

-

-

(1,036.40)

(1,036.40)

As at 31 December 2023

1,008.45

2,410.22

720.31

(46.75)

29,868.20

33,960.43

5,042.25

39,002.67

-

-

-

-

Cash Flow Statements

Company

Group

For the period ended 31 December

2024

2023

2024

2023

(In Rs. MN's)

Cash flow from operating activities

Cash generated from operations (Note A)

673.22

339.74

7,851.88

6,738.98

Interest paid

(1,304.84)

(1,744.59)

(1,792.83)

(2,666.67)

Retirement benefit costs paid

21.01

(6.44)

(6.66)

(34.61)

Income tax paid

(66.00)

(309.33)

(2,176.08)

(2,388.48)

Net cash inflow/(outflow) from operating activities

(676.61)

(1,720.62)

3,876.31

1,649.22

Cash flow from investing activities

Addition to property, plant & equipment and CWIP

(109.08)

(110.54)

(777.20)

(555.44)

Addition to biological assets

-

-

(402.66)

(432.20)

Addition to intangible assets

-

-

-

(4.18)

Proceeds from disposal of property, plant & equipment

0.52

1.24

8.15

5.97

Proceeds from disposal of assets held for distribution and sale

-

800.05

-

800.05

Proceeds from sale of biological assets

-

-

0.68

2.18

Disposal of rights

48.00

-

-

-

Dividend received from subsidiaries

155.85

1,630.90

-

-

Dividend received from equity accounted investees

363.26

256.57

433.14

263.91

Dividend received from other financial assets

0.77

20.47

9.58

27.67

Interest income received

158.38

217.46

557.59

640.06

Further investment in subsidiary

(0.01)

(200.00)

-

(200.00)

Further investment in associate

(811.18)

-

(3,470.72)

-

Other long-term investments

-

(7,469.91)

-

(7,469.91)

Other short-term investments

-

-

(18.68)

(257.94)

Subsidiary dividends to non-controlling interest

-

-

(118.66)

(1,036.40)

investments in banks

(5.90)

(73.68)

(315.90)

(80.37)

Net cash outflow from investing activities

(199.39)

(4,927.44)

(4,094.68)

(8,296.60)

Net Cash outflow before financing activities

(876.00)

(6,648.06)

(218.37)

(6,647.38)

Cash flow from financing activities

Dividends paid

(947.70)

(947.70)

(947.70)

(947.70)

Net Long term loan received/(settled)

1,917.11

(8.20)

1,838.41

(92.44)

Net cash inflow/(outflow) from financing activities

969.41

(955.90)

890.71

(1,040.14)

Net increase / (decrease) in cash & cash

equivalents during the period

93.41

(7,603.96)

672.34

(7,687.52)

Cash & cash equivalents at the beginning of the period

(17,613.76)

(9,437.92)

(19,498.47)

(12,875.99)

Cash & cash equivalents at the end of the period (Note B)

(17,520.35)

(17,041.88)

(18,826.13)

(20,563.51)

Note A - Cash generated from operations

Profit before tax from continuing operations

1,324.93

2,165.50

7,649.81

12,230.60

Profit/(Loss) before interest and tax from discontinued operations

(0.75)

(0.15)

14.11

17.54

Adjustments for:

Depreciation on property, plant & equipment

103.05

114.56

682.39

666.50

Amortization of Intangible assets

5.92

5.92

20.42

19.73

Amortization of right use asset

4.14

4.14

78.15

51.09

Gain on disposal of property, plant & equipment

(0.52)

(0.77)

(3.07)

(2.86)

Provision for retirement benefit

47.96

37.54

179.51

141.32

Amortization of biological assets and change due to harvest

-

-

494.39

328.78

Grants amortised

-

-

(0.13)

(0.13)

Loss on disposal of assets classified as held for sale

-

103.74

-

103.74

Write off of property, plant and equipment

-

-

0.10

2.39

Profits from sale of Rights

(48.00)

-

-

-

Interest income

(158.38)

(217.46)

(557.59)

(640.06)

Interest expense

1,310.73

1,750.72

1,821.58

2,689.18

Share of profit of equity accounted investees

-

(539.72)

(5,574.13)

Dividend income

(519.88)

(1,907.94)

(9.58)

(27.67)

Operating profit before working capital changes

2,069.20

2,055.80

9,830.37

10,006.02

Increase in trade and other receivables

(1,670.50)

(1,076.78)

(4,693.96)

(4,434.12)

Decrease in inventories

333.81

466.27

1,944.92

734.13

(Decrease)/increase in trade and other payables

(59.29)

(1,105.55)

770.55

432.95

Cash generated from operations

673.22

339.74

7,851.88

6,738.98

Note B - Analysis of cash & cash equivalents

at the end of the period

Cash in hand and at bank

920.69

648.65

6,275.51

6,342.81

Interest bearing short-term borrowings

(18,441.04)

(17,690.53)

(25,101.64)

(26,906.32)

(17,520.35)

(17,041.88)

(18,826.13)

(20,563.51)

For the Period ended 31st December

2024

2023

(a)

Segmental Revenue

Crop Solutions

28,056.78

28,091.17

Agri Produce

4,354.60

4,172.85

Livestock Solutions

13,346.90

11,520.87

Industrial Solutions

6,067.10

5,496.95

Health & Personal Care

14,289.44

12,098.65

Total Revenue

66,114.82

61,380.49

Intra-group sales

(1,451.91)

(1,223.50)

Net Revenue

64,662.91

60,156.99

(b)

Segmental Results

Crop Solutions

3,853.42

4,486.53

Agri Produce

391.32

205.28

Lives stock Solutions

1,387.89

1,481.52

Industrial Solutions

1,032.74

1,061.01

Health & Personal Care

1,693.18

1,413.02

Net Segmental Results

8,358.55

8,647.36

Unallocated expenses

(188.94)

(153.40)

Other income

219.40

229.54

Financing costs

(1,278.92)

(2,067.03)

Gain on Bargain Purchase

473.45

5,121.70

Loss on dilution of investment in associate

(19.61)

-

Share of profit from equity accounted investees

539.72

452.43

Tax expense

(2,420.02)

(2,580.64)

Profit from continuing operations

5,683.64

9,649.96

Profit from discontinued operations (net of tax)

14.09

17.49

Profit for the period

5,697.73

9,667.45

Attributable to:

Equity holders of the Company

4,853.62

8,647.38

Non- controlling interest

844.11

1,020.07

Profit for the period

5,697.73

9,667.45

Note :

The above figures are provisional and unaudited.

Figures in brackets indicate deductions.

Company

Group

For the period ended 31 December

2024

2023

2024

2023

(In Rs. Mns)

1 Other Income

Rent income

19.99

18.91

9.92

9.22

Divided income

519.88

1,907.94

9.58

27.67

Gain on disposal of property, plant and equipment

0.52

0.77

3.23

2.86

Direct sales commission

6.57

33.07

72.76

59.09

Grants amortised

-

-

0.13

0.13

Profit from sale of rights

48.00

-

-

-

Sundry income

0.01

0.47

123.78

130.57

594.97

1,961.16

219.40

229.54

2 Financing Cost (Net)

Finance cost

Interest on loans

1,304.84

1,744.59

1,796.61

2,675.37

Interest on leases

5.89

6.13

39.90

31.72

1,310.73

1,750.72

1,836.51

2,707.09

Finance income

Exchange gain

86.81

120.55

235.81

344.23

Interest income

71.57

96.91

321.78

295.83

158.38

217.46

557.59

640.06

Net financing cost

1,152.35

1,533.26

1,278.92

2,067.03

3 Market Value of Shares

For the three months ended 31 December

2024

2023

Voting

Non-Voting

Voting

Non-Voting

Rs.

Rs.

Rs.

Rs.

Highest

97.50

69.00

76.40

57.90

Lowest

72.10

52.50

62.80

40.00

Period end

94.00

67.00

64.00

42.50

4 Market Capitalisation

Type

No.of Shares

Share price

Capitalisation

Rs.

Rs.

Ordinary Shares

291,600,000

94.00

27,410,400,000

Non-Voting (Class X)

87,480,000

67.00

5,861,160,000

5 Float Adjusted Market Capitalisation

Type

No.of Shares

Share price

Capitalisation

Rs.

Rs.

Ordinary Shares

136,150,684

94.00

12,798,164,296

Non-Voting (Class X)

84,432,773

67.00

5,656,995,791

18,455,160,087

As the float adjusted market capitalisation is above 10.0Bn, CIC Holdings PLC complies under option 1 with the minimum public holding

requirement.

6 Number of Shares

Number of Shares

Share Capital (Rs)

As at end of 31 December

2024

2023

2024

2023

Ordinary Shares

291,600,000

291,600,000

789,750,000

789,750,000

Non-Voting (Class X)

87,480,000

87,480,000

218,700,000

218,700,000

Total

379,080,000

379,080,000

1,008,450,000

1,008,450,000

7 Dividend Paid

2023/24

2022/23

Voting

Non-Voting

Voting

Non-Voting

Rs.

Rs.

Rs.

Rs.

Final dividend per share -Rs.2.50 (2023/24)-Rs.2.50 (2022/23)

2.50

2.50

2.50

2.50

2.50

2.50

2.50

2.50

Group

Level 01

Level 03

As at 31 December

2024

2023

2024

2023

Recurring fair value measurements-

Freehold land

4,657.29

4,651.58

Biological assets

759.23

891.00

Equity investments

529.46

259.38

529.46

259.38

5,416.52

5,542.58

Non-recurring fair value measurements

Net assets classified as held for distribution

16.10

(33.13)

Other

Net assets

components of

attributable to the

Rs.Mn

Stated capital

Revenue reserves

equity

parent

As at 30 June 2024

91,240.26

128,887.45

137,560.21

357,687.92

Net assets attributable to CIC Group - 30 June 2024

23.71

33.50

35.75

92.96

As at 30 September 2024

91,250.15

130,365.59

134,619.15

356,234.89

Net assets attributable to CIC Group - 30 September 2024

7.99

11.29

19.90

39.18

As at 31 December 2024

115,327.06

132,527.07

137,242.97

385,097.11

Net assets attributable to CIC Group - 31 December 2024

2,354.00

513.86

944.16

3,812.02

Net assets attributable

3,944.17

Cost of the investment

3,470.72

Gain on bargain purchase

473.45

Rs.Mn

Net assets applicable to CIC Group before dilution

23,950.29

Net assets applicable to CIC Group after dilution

23,930.69

Loss on dilution of investment in John Keells Holdings PLC

(19.61)

1

Twenty Largest Shareholders

VOTING (ORDINARY) SHARES

Name

No. of Shares

Percentage %

1

Paints & General Industries Limited

155,441,396

53.31

2

Employee's Provident Fund

26,417,892

9.06

3

Sampath Bank PLC/ Chacra Capital Holdings (Private) Limited

13,104,960

4.49

4

Asia Securities (Private) Limited - Trading Account

5,040,000

1.73

5

Citibank Newyork S/A Norges Bank Account 2

4,258,258

1.46

6

Ms. J. Ambani

4,209,241

1.44

7

Senkadagala Finance PLC/ Mr. R.S.H. Nanayakkara & R.M. Nanayakkara

3,578,980

1.23

8

Sri Lanka Insurance Corporation Limited - Life Fund

3,104,855

1.06

9

Employees Trust Fund Board

2,373,335

0.81

10

Ranavav Holdings (Private) Limited

2,116,400

0.73

11

Mr. H. Yusoof

2,035,727

0.70

12

Dr. H.R. Wickremesinghe & Mr. V.K. Wickremasinghe

1,752,242

0.60

13

Amana Bank PLC/ Hi-Line Trading (Private) Limited

1,384,254

0.47

14

S.K. Wickremesinghe Trust (Gurantee) Limited

1,360,000

0.47

15

Seylan Bank PLC/ ARRC Capital (Private) Limited

1,340,411

0.46

16

Colombo Fort Investments PLC

1,245,000

0.43

17

Ms. L.K. Goonewardena

1,205,120

0.41

18

Ms. N.K.R.H. De Silva

1,135,700

0.39

19

Seylan Bank PLC/ Andaradeniya Estate (Private) Limited

1,088,300

0.37

20

Sampath Bank PLC/ Andaradeniya Estate (Private) Limited

1,075,587

0.37

233,267,658

80.00

Total Number of Shares Issued - 291,600,000 Ordinary Shares

CIC HOLDINGS PLC

Twenty Largest Shareholders.Cont…

2

NON-VOTING (CLASS 'X') SHARES

Name

No. of Shares

Percentage %

1

Employee's Provident Fund

11,113,696

12.70

2

Sampath Bank PLC/ Chacra Capital Holdings (Private) Limited

6,184,280

7.07

3

Paints & General Industries Limited

2,905,204

3.32

4

Seylan Bank PLC/ Mr. W.G.U.I. Ranaweera

2,059,290

2.35

5

DFCC Bank A/C No.01

1,630,000

1.86

6

Ms. D Ramesh & Mr. P. Ramesh

1,134,770

1.30

7

Winsland Reality (Private) Limited

1,087,210

1.24

8

Mr. H. Yusoof

999,878

1.14

9

Hatton National Bank PLC - NDB Wealth Growth and Income Fund

800,000

0.91

10

Seylan Bank PLC/ Hotel International (Private) Limited

731,942

0.84

11

Seylan Bank PLC/ Mr. A.C. Senanka

722,470

0.83

12

Hatton National Bank PLC/ Mr. G.S.N. Peiris & Ms. I.R Peiris

687,689

0.79

13

GF Capital Global Limited

641,916

0.73

14

Malship Ceylon Limited

534,528

0.61

15

Senkadagala Finance PLC/ Mr. M.M. Fuad

505,000

0.58

16

Thread Capital (Private) Limited

501,302

0.57

17

Nagoya Ceylon (Private) Limited

500,000

0.57

18

Ms. S. Vasudevan & Mr. S. Vasudevan

500,000

0.57

19

Synamon Global (Private) Limited

492,893

0.56

20

Mr. E.J.B.U. Fernando

487,705

0.56

34,219,773

39.12